Add Company
Join Now

Palisade Capital Management Revenue and Competitors

License our Company Data API

Fort Lee, NJ USA

Location

N/A

Total Funding

Investments

Industry

Estimated Revenue & Valuation

  • Palisade Capital Management's estimated annual revenue is currently $8.4M per year.(i)
  • Palisade Capital Management's estimated revenue per employee is $189,855

Employee Data

  • Palisade Capital Management has 44 Employees.(i)
  • Palisade Capital Management grew their employee count by 2% last year.

Palisade Capital Management's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
Chief Investment OfficerReveal Email/Phone
3
VP, Institutional Client Service & Marketing AnalyticsReveal Email/Phone
4
VP AdministrationReveal Email/Phone
5
VP ResearchReveal Email/Phone
6
AVP, Client Relations & Strategic InitiativesReveal Email/Phone
7
AVPReveal Email/Phone
8
SVP, Head Consultant RelationsReveal Email/Phone
9
VP Private Wealth ManagementReveal Email/Phone
10
Partner, General Counsel & Chief Compliance OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.4M4653%N/AN/A
#2
$14.1M9952%N/AN/A
#3
$5.6M28-3%N/AN/A
#4
$1029.7M324080900%N/AN/A
#5
$19.3M8521%N/AN/A
#6
N/A7030%N/AN/A
#7
$17.3M757%N/AN/A
#8
$4.3M3436%N/AN/A
#9
N/A6-50%N/AN/A
#10
$22.5M9927%N/AN/A
Add Company

What Is Palisade Capital Management?

At Palisade Capital, we provide investment management services to large institutions through our Small-Cap Equity and Convertible Security strategies. Through the proper balancing of risk and reward we endeavor to provide meaningful returns while preserving clients’ capital.

keywords:N/A

N/A

Total Funding

44

Number of Employees

$8.4M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Palisade Capital Management News

2022-04-19 - Castle Biosciences (NASDAQ:CSTL) Upgraded to Hold at ...

Finally, Palisade Capital Management LLC NJ purchased a new stake in Castle Biosciences during the fourth quarter valued at about...

2022-04-17 - Zacks: Analysts Expect Heron Therapeutics, Inc. (NASDAQ ...

Zacks Investment Research's earnings per share calculations are a mean ... Palisade Capital Management LLC NJ now owns 3,034,172 shares of...

2016-04-19 - Australia: CEFC, Palisade outline $1b investment plan for renewable energy projects

Premium Australia’s Clean Energy Finance Corp (CEFC) and Palisade Investment Partners (Palisade) have laid out a $1 billion investment plan to boost the development of local renewable energy (RE) projects. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.4M4522%N/A
#2
$2.9M4664%N/A
#3
$4.8M47-4%N/A
#4
$10M482%N/A
#5
$19.5M54-8%N/A